| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
( Lilly Research Laboratories, Indianapolis, Indiana)
Simple procedures are described for the establishment and maintenance of continuous fluid mass cultures of mammalian cells, free-living nonparasitic protozoa, and nonfilamentous green algae, for laboratory use. These cultures served as production units to provide morphologically homologous but phylogenetically diverse organisms for use in large-scale drug testing. All these organisms were incorporated into agar-bioautograph systems, as well as into fluid cultures for turbidimetric studies with drugs of the antimicrobial and antitumor type. A comparative study was made in both fluid and agar systems utilizing the two mammalian cell strainsHeLa and NCTC 1742; the three protozoaEuglena gracilis, Tetrahymena pyriformis and Ochromonas malhamensis; and the green algaeScenedesmus basiliensis and Chlorella vulgaris. The algae, Scenedesmus basiliensis, was the most sensitive organism studied. In agar systems the protozoa were superior to the mammalian cells in terms of detecting clinically useful cancer drugs, but less sensitive in terms of numbers of drugs detected. They were sensitive enough for mechanism of action studies. It is suggested that the nonparasitic protozoa in particular and protozoa and algae in general have not been thoroughly exploited for their potential use in industrial biological research.
* Presented in part in a Symposium on Mass Cell Propagation during the 140th Meeting of the American Chemical Society, Chicago, Illinois, September, 1961.
Received 12/ 8/61.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |